Sort
48,018 grants matching “immunotherapy”
Tumor Growth and Microenvironment Influence T Cell Tolerance to Tumor Antigens
$720,716Arthur Hurwitz · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Building better T cell receptors for targeted immunotherapy
$720,706Brian M Baker · University Of Notre Dame · R01 · FY2018 · AI
Data-driven inference of regulators for cytokine-mediated tumor killing
$720,674Peng Jiang · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Computational approaches for the analyses of spatial profiling technologies
$720,674Peng Jiang · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
CD4 T cell control of cytomegalovirus
$720,659Christopher A Benedict · La Jolla Institute For Immunology · R01 · FY2019 · AI
CD4 T cell control of cytomegalovirus
$720,659Christopher A Benedict · La Jolla Institute For Immunology · R01 · FY2020 · AI
Development of Broadly Protective Vaccines against New World Arenaviruses
$720,588Yuying Liang · University Of Minnesota · R01 · FY2025 · AI
Depleting exosomes to improve responses to immune therapy in HNSCC
$720,532Theresa L. Whiteside · University Of Pittsburgh At Pittsburgh · U01 · FY2021 · DE
Theranostic DLL3/PSMA-bi-specific CAR-T cells for prostate cancer therapy
$720,416Vladimir Ponomarev · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA
Mechanism of action and therapeutic utility of stimulatory CpG oligonucleotides
$720,328Dennis Klinman · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Systems-level identification of key regulators deciding immune cell state
$720,299Wei Wang · University Of California, San Diego · R01 · FY2022 · AI
Project 1: Perturbation of Pre-Existing Immunity to Chronic Viral Infection Through Immunotherapy
$720,185Georg Michael Lauer · Massachusetts General Hospital · U19 · FY2019 · AI
Understanding and manipulating programmed cell death (PCD) pathways to facilitate lymphoid tumor killing by CAR T cells
$720,152Marcela Valderrama Maus · Massachusetts General Hospital · R01 · FY2021 · CA
TLR5 enhancement of liver-directed radiotherapy plus immune checkpoint blockade against irradiated liver metastasis and abscopal tumors
$720,023Craig M. Brackett · Roswell Park Cancer Institute Corp · R01 · FY2023 · CA
Systems genetics analysis of tumor evolution in the mouse
$720,018Allan Balmain · University Of California, San Francisco · R35 · FY2017 · CA
IMMUNOTHERAPY TARGETING STROMAL CD5L IN OVARIAN CANCER
$720,001The Univeristy Of Texas M.D. Anderson Cancer Center · · FY2020 · Defense Health Agency
Transformable Theranostics for imaging-guided interventions in head and neck squamous cell carcinoma
$719,958Tzu-Yin Lin · Theranostec, Inc. · R44 · FY2024 · CA
A Pathway for Necrotic Cell Death
$719,845David J Shapiro · University Of Illinois At Urbana-Champaign · R01 · FY2025 · CA
Regulation of CTCF Functions and Target Sites by Cancer/Testis-specific CTCF Like BORIS Factor
$719,820Victor Lobanenkov · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Probing cytosolic nucleic acid sensing pathways in cancer
$719,771Ashley Marie Laughney · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · CA
Regulation of Expression and Mechanism of Action of Granulysin and RANTES
$719,644Alan Krensky · Basic Sciences · Z01 · FY2007 · CA
ISLET TOLERANCE INDUCTION BASED ON ANTI-CD154 ANTIBODY
$719,594Univ Of Massachusetts Med Sch Worcester · R01 · FY2000 · DK
Intracerebroventricular (ICV) Administration of CD19-Targeting Chimeric Antigen Receptor (CAR) T cells for Treatment of Primary Central Nervous System Lymphoma
$719,558Xiuli Wang · Beckman Research Institute/City Of Hope · R01 · FY2022 · CA
Preclinical development of breakthrough immunotherapy for brain tumors
$719,525Hideho Okada · University Of California, San Francisco · R35 · FY2019 · NS
Enhancing B7-H3-CAR T cell therapy for pediatric solid tumors
$719,445Christopher C. Derenzo · St. Jude Children'S Research Hospital · R01 · FY2023 · CA